Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells

Circulation

Volumn 106, Issue 12, 2002, Pages 1439-1441

  Venugopal, Senthil Kumar ^a   Devaraj, Sridevi ^a   Yuhanna, Ivan ^a   Shaul, Philip ^a   Jialal, Ishwarlal ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

C reactive protein; Endothelium; Inflammation; Nitric oxide synthase

Indexed keywords

C REACTIVE PROTEIN; CYCLIC GMP; NITRIC OXIDE SYNTHASE;

AORTA; ARTICLE; CELL ADHESION; CELL CULTURE; CELL LEVEL; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; ENDOTHELIUM CELL; ENZYME ACTIVITY; HUMAN; HUMAN CELL; INCUBATION TIME; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AORTA; C-REACTIVE PROTEIN; CELL ADHESION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; ENDOTHELIUM, VASCULAR; HUMANS; MONOCYTES; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 0037126012     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000033116.22237.F9     Document Type: Article

References (20)

1. Inflammation and atherosclerosis
2. The prognostic value of CRP protein and serum amyloid A protein in severe unstable angina
3. CRP is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: A TIMI 11A substudy
4. Inflammation markers and coronary heart disease
5. High-sensitivity C-reactive protein: Potential adjunct for global risk assessment in the primary prevention of cardiovascular disease
6. Inflammation and atherosclerosis: The value of the high-sensitivity C-reactive protein assay as a risk marker
7. C-reactive protein in the arterial intima: Role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis
8. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor
9. Direct proinflammatory effect of C-reactive protein on human endothelial cells
10. Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs
11. Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein
12. Atherosclerosis and the two faces of endothelial nitric oxide synthase
13. Nitric oxide and vascular disease
14. The L-arginine-nitric oxide pathway: Role in atherosclerosis and therapeutic implications
15. Alpha-tocopherol decreases interleukin-1 beta release from activated human monocytes by inhibition of 5-lipoxygenase
16. Acylation targets endothelial nitric oxide synthase to plasmalemmal caveolae
17. Alpha-tocopherol enrichment of monocytes decreases agonist-induced adhesion to human endothelial cells
18. Elevated CRP and impaired endothelial reactivity in patients with CAD
19. Endothelial dysfunction as a possible link between C-reactive protein levels and cardiovascular disease
20. Inflammatory cytokines impair endothelium-dependent dilatation in human veins in-vivo